AHR:NYE-American Healthcare REIT, Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 34.84

Change

+0.13 (+0.37)%

Market Cap

USD 5.17B

Volume

1.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.21 (+0.79%)

USD 97.26B
VTR Ventas Inc

+0.07 (+0.11%)

USD 28.94B
DOC Healthpeak Properties Inc

-0.11 (-0.63%)

USD 11.70B
CTRE CareTrust REIT Inc.

+0.21 (+0.74%)

USD 5.46B
CWSRF Chartwell Retirement Residence..

+0.25 (+1.90%)

USD 3.71B
NHI National Health Investors Inc

-0.42 (-0.58%)

USD 3.38B
LTC LTC Properties Inc

+0.02 (+0.06%)

USD 1.65B
UHT Universal Health Realty Income..

+0.27 (+0.68%)

USD 0.53B
CHCT Community Healthcare Trust Inc

-0.07 (-0.43%)

USD 0.45B
GMRE-PA Global Medical REIT Inc

+0.06 (+0.24%)

USD 0.40B

ETFs Containing AHR

BYRE Principal Exchange-Traded.. 5.86 % 0.00 %

+0.10 (+0.12%)

USD 0.01B
FSCC Federated Hermes ETF Trus.. 1.52 % 0.00 %

+0.03 (+0.12%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.59% 100% F 94% A
Dividend Return 0.88% 15% F 36% F
Total Return 23.47% 100% F 94% A
Trailing 12 Months  
Capital Gain 143.47% 100% F 99% N/A
Dividend Return 5.24% 40% F 75% C
Total Return 148.71% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.93% 93% A 85% B
Dividend Return 21.63% 93% A 84% B
Total Return 0.70% 7% C- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 48.58% 7% C- 16% F
Risk Adjusted Return 44.53% 53% F 61% D-
Market Capitalization 5.17B 60% D- 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.